Comparison of 3D conformal radiation therapy and intensity-modulated radiation therapy in patients with endometrial cancer: efficacy, safety and prognostic analysis Minh-Hanh Ta Antoine Schernberg Paul Giraud Laurie Monnier Émile Darai Sofiane Bendifallah Michel Schlienger Emmanuel Touboul Alexandre Orthuon Thierry Challand Florence Huguet Eleonor Rivin del Campo 10.6084/m9.figshare.8034557.v1 https://tandf.figshare.com/articles/journal_contribution/Comparison_of_3D_conformal_radiation_therapy_and_intensity-modulated_radiation_therapy_in_patients_with_endometrial_cancer_efficacy_safety_and_prognostic_analysis/8034557 <p><b>Introduction:</b> Adjuvant whole-pelvic radiation therapy (WPRT) improves locoregional control for high-intermediate stages I–III endometrial cancer patients. Intensity modulated radiation therapy (IMRT) tends to replace the standard 3D conformal radiation therapy (3DCRT) technique used in trials.</p> <p><b>Material and methods:</b> Consecutive patients with stages I–IIIc endometrial cancer treated between 2008 and 2014 in our department with post-operative 3DCRT or IMRT WPRT were studied retrospectively. Patients with cervical involvement underwent additional low-dose rate vaginal brachytherapy. The impact of the WPRT technique on local control, tolerance, disease-free survival (DFS) and overall survival (OS) was assessed. Clinicians evaluated routinely acute radiation toxicity each week during radiation therapy and late toxicity during standard follow-up consultations.</p> <p><b>Results:</b> Median follow-up was 50 months (range: 6–158). Among the 83 patients included, 47 were treated with 3DCRT and 36 with IMRT. There was no difference in patient characteristics between groups. The 5-year locoregional control and DFS rates were 94.5% and 68%, respectively. No significant difference was found between the 3DCRT and IMRT groups in terms of survival, with 5-year OS rates of 74.6% and 78%, respectively. In multivariate analysis, age over 68, stage > T1 and grade 3 were independently associated with shorter DFS and OS. Seven patients (8.4%) had grades 3–4 acute gastrointestinal (GI) toxicity with five patients (10.6%) and two (5.4%) in the 3DCRT and IMRT groups, respectively (<i>p</i> = .69). One case (1.2%) of late grade 3 GI toxicity was observed treated in 3DCRT.</p> <p><b>Conclusions:</b> IMRT seems to be a safe technique for the treatment of endometrial cancer with a trend towards decreased acute GI toxicities. Results of the phase 3 RTOG 1203 trial are needed to confirm these results.</p> 2019-04-24 10:01:57 phase 3 RTOG 1203 trial 5- year locoregional control technique intensity-modulated radiation therapy 3 D conformal radiation therapy survival IMRT groups WPRT endometrial cancer 3 DCRT prognostic analysis Introduction Adjuvant whole-pelvic radiation therapy 5- year OS rates DFS radiation therapy grade 3 GI toxicity